Clinical Trials - CLRB

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT05610891Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGGACTIVE_NOT_RECRUITINGPHASE12023-10-012026-092026-05
NCT03478462Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and OsteosarcomaACTIVE_NOT_RECRUITINGPHASE12019-04-302026-122025-12-25
NCT02952508Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom MacroglobulinemiaACTIVE_NOT_RECRUITINGPHASE22017-07-262026-12-222025-12-22
NCT02278315Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12015-022022-08-102020-12-09
NCT01778088Open-Label Study of I-131-CLR1404 in Subjects With Recurrent GliomaWITHDRAWNPHASE22014-052015-012014-06
NCT01898273Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent GlioblastomaTERMINATEDPHASE22014-022015-122015-09
NCT01495663Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has ReturnedCOMPLETEDPHASE12011-122014-012013-11
NCT01058512A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard TherapyCOMPLETEDPHASE22010-032010-122010-12
NCT00925275Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid TumorsCOMPLETEDPHASE12009-062010-022010-02
NCT00347412Study of NOV-002 in Combination With Chemotherapy to Treat Lung CancerCOMPLETEDPHASE32006-112010-022010-01
NCT00372983Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard TherapyCOMPLETEDPHASE12006-082007-12
NCT00345540Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian CancerCOMPLETEDPHASE22006-072008-062008-05